Diabetes Technology & Therapeutics
All submitted and accepted abstracts for ATTD-ASIA 2025 will be published together with the abstracts of the 19th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2026) in the Diabetes Technology & Therapeutics journal (DTT), the official journal of ATTD, and will be available from 11 March 2026.
The Diabetes Technology & Therapeutics journal, led by Editor-in-Chief Satish K. Garg, MD, Diabetes Technology & Therapeutics, is the only peer-reviewed journal providing information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes.
This leading international journal delivers practical information and comprehensive coverage of the latest technologies and therapeutics in the field. Each issue highlights new pharmacological and device developments to optimize patient care.
- To view the ATTD 2025 Abstracts published in the DTT Journal, click here to download (pdf file).